Center for Emerging and Infectious Diseases

The Center for Emerging and Infectious Diseases (CEID) will contribute to the ongoing advancement of diagnostic testing, enabling rapid and accurate identification of infectious agents. The center’s researchers will engage with local and global communities to better understand disease transmission patterns, devise evidence-based strategies for prevention and control, and enhance public health preparedness. The epidemiological work that will take place within CEID will allow public health agencies to make informed decisions, particularly in times of urgent need, and allocate resources effectively.

“The mission of the Center for Emerging and Infectious Diseases is to develop, evaluate and implement effective countermeasures against existing and emerging infectious disease threats,” said Marcus Zervos, M.D., co-director of the center. “Along with co-directors Teena Chopra, M.D., MPH, and Paul Kilgore, M.D., CEID will conduct basic, clinical and applied research to accelerate development and introduction of vaccines and related interventions to control emerging and re-emerging infectious diseases affecting populations in Detroit, Michigan, the United States and around the world. This center will be a unique resource within the Wayne State University and Detroit communities and beyond that will enable rapid implementation of research teams to prepare clinical vaccine trials in outpatient, inpatient and community settings.”

CEID’s programs will provide credible, evidence-based information to guide informed decision-making for participation in clinical trials as well as utilization of proven tools that enhance preparedness and protect communities from diseases of epidemic and pandemic potential.

“It is our goal to be an important resource for many to understand emerging and infectious diseases that have increased mortality and morbidity impact,” said Zervos. “In particular, communities such as Detroit often have less direct access to information, and the center will play a critical role in providing our citizens with critical communications that can ultimately impact the health of themselves as well as their friends and family.”

“CEID’s state-of-the-art microbiology laboratory has capabilities for rapid detection of emerging and re-emerging infectious diseases,” said Chopra. “This will provide quality and timely care to Detroit residents.”

Hossein Salimnia, Ph.D., serves as the microbiology director of the lab and Chopra is the medical director.

Ben L. Silberstein Institute for Brain Health

The Ben L. Silberstein Institute for Brain Health (IBH) will advance the understanding of the brain’s structure, chemistry and function as it relates to both disease and the promotion of health and well-being. It will accelerate and promote team interactional science through biomedical imaging platforms, neurogenetics, addiction and pain biology, post-traumatic stress disorder and trauma neurobiology, gerontology nanotechnology, neurodevelopment, targeting and reducing health care disparities, and innovative and novel diagnostic and treatment development.

“The Ben L. Silberstein Institute for Brain Health will bring together transdisciplinary, cross-campus neuroscience researchers, as well as combine undergraduate, graduate and post-doctoral neuroscience education to focus on health equity and challenges related to brain and behavioral health in urban environments, particularly in Southeast Michigan and Detroit,” said David Rosenberg, co-director of IBH. “It is our goal to make a significant impact on promoting brain health by targeting and accelerating diagnostic and therapeutic advances for real-world childhood and adult-onset brain disorders impacting our community and beyond.”

IBH aims to be a leader in translational neurosciences and inspire the next generation of students and researchers to improve the health and care of individuals affected by psychiatric or neurological disorders or injuries in the nervous system. The institute will identify mechanisms promoting brain health as well as enhancing the understanding of disease mechanisms as it can related to enhanced diagnosis and treatment, ultimately aiding many with real-world childhood and adult-onset brain disorders.

“IBH will work with strategic partners and faculty across campus to improve lives through important research and community outreach that will provide diagnosis and new treatments for many psychiatric and brain disorders,” said Rosenberg. “By building a large collaborative team, we are now better able to facilitate the important work that needs to be done to help the lives of so many impacted by brain health issues.”

“Wayne State University is committed to improving the lives of our community and beyond, and through the Center for Emerging and Infectious Diseases and the Ben L. Silberstein Institute for Brain Health, we are now well positioned to be a leader in Detroit for advancing research, technology development and education in these critical health areas,” said Stemmler. “Collaboration is a critical component of research, and these two institutes will be excellent examples of how bringing disciplines from across campus together can lead to groundbreaking discoveries that will improve lives.”

###

About Wayne State University

Wayne State University is one of the nation’s pre-eminent public research universities in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. For more information about research at Wayne State University, visit research.wayne.edu.

Contact info
Julie O’Connor
Director, Research Communications
Phone: 313-577-8845
Email: julie.oconnor@wayne.edu

Providencia rettgeri, while not as widely recognized as other pathogens, has posed unique challenges within healthcare environments. This bacterium is notorious for its potential to cause infections in immunocompromised patients, making it a particular concern during times when healthcare systems are stretched thin, such as during the ongoing pandemic. The recent corrections to the original article highlight the importance of accuracy in reporting findings in epidemiological studies, ensuring that health officials and the scientific community can respond effectively to emerging threats.

The outbreak investigated by this research team unfolded in a university hospital setting, where the intersection of complex healthcare needs and a significant patient population intensified the risk of infection transmission. With COVID-19 forcing hospitals worldwide to adapt rapidly to changing patient care scenarios, the concern over secondary infections has never been more substantial. Providencia rettgeri is predominantly opportunistic; thus, its emergence during a pandemic warrants thorough investigation.

The researchers relied on a robust methodology that combined epidemiological tracking with molecular analysis. By analyzing the genetic makeup of the isolated strains, the team aimed to determine potential transmission routes and the resistance mechanisms at play. Understanding how these bacteria adapted to survive in a hospital environment could provide invaluable insights into improving infection control practices.

One of the critical findings highlighted in the study was the presence of antibiotic resistance among the strains of Providencia rettgeri collected from patients. This resistance poses a dual threat: not only does it complicate treatment efforts, but it also makes containment strategies more challenging to implement. The study emphasizes the urgent need for ongoing surveillance of antibiotic-resistant pathogens, particularly in settings with high-risk populations.

Further, the researchers underscored the role of environmental factors in facilitating the outbreak. The close quarters and shared spaces typical of hospital environments can serve as breeding grounds for infections. Coupled with the increased foot traffic from COVID-19 patients requiring intensive care, the conditions were ripe for the bacterium to establish itself. This finding serves as a stark reminder of the interconnectedness of various healthcare challenges, particularly during public health emergencies.

In addressing the epidemiological and molecular aspects of the outbreak, the research raises essential questions about the mechanisms of bacterium transmission. The researchers found evidence suggesting the possibility of both person-to-person and environmental transmission. Identifying the precise vectors of infection is crucial for devising targeted interventions to curb further outbreaks in similar settings.

Moreover, the emotional and psychological toll of such outbreaks on healthcare workers and patients cannot be overlooked. Strained by the demands of treating COVID-19 patients, healthcare professionals may also face the added burden of managing outbreaks from opportunistic pathogens like Providencia rettgeri. Acknowledging this aspect is essential in understanding the broader implications of infectious disease outbreaks.

The retrospective nature of the study also allows researchers to draw valuable lessons that could inform future responses to similar situations. As the pandemic has unveiled vulnerabilities in healthcare systems worldwide, the need for adaptive, rapid-response strategies in infection control has never been clearer. Building resilience within hospital infrastructures can help mitigate risks associated with both viral and bacterial infections.

This research highlights the significance of collaboration in addressing public health challenges. By bringing together biologists, epidemiologists, and healthcare professionals, the team was able to create a comprehensive picture of the outbreak. Such interdisciplinary partnerships are vital in formulating effective public health policies, particularly in environments where infectious diseases are prevalent.

As the study progresses through the correction phase, it also serves as a reminder of the importance of peer review and rigorous scientific discourse. The corrections acknowledge the dynamic nature of research and the need for continual refinement of findings. In an era of rapid scientific advancement, ensuring accuracy in published studies is vital for the integrity of the field and public health at large.

In conclusion, the comprehensive investigation into the Providencia rettgeri outbreak during a COVID-19 reference center underscores the complex landscape of infectious diseases that healthcare systems must navigate. By understanding the epidemiological and molecular characteristics of such pathogens, healthcare professionals and researchers can better prepare for future outbreaks. This research not only contributes to the academic understanding of Providencia rettgeri but also reinforces the essential nature of vigilant public health strategies in safeguarding vulnerable populations.

Ultimately, the findings from this study highlight the interconnectedness of various health challenges exacerbated by the COVID-19 pandemic. As the world continues to recover from this global crisis, the insights gleaned from this research could pave the way for more robust infection control measures. The lessons learned here will resonate well beyond a single outbreak, emphasizing the need for sustained vigilance and proactive strategies in the face of ever-evolving public health threats.

In a world where new pathogens are continually emerging alongside existing ones, studies like this remind us of the ongoing battle against infectious diseases. The collaboration showcased in this research is a beacon of hope, suggesting that with continued effort, vigilance, and scientific advancement, healthcare environments can evolve to better protect themselves and their patients from the threats posed by pathogens such as Providencia rettgeri.

Subject of Research: Epidemiological and molecular study of Providencia rettgeri outbreak

Article Title: Correction to: Epidemiological and molecular study of Providencia rettgeri outbreak at a university hospital during the COVID‑19 reference center

Article References:

Da Silva Pimenta, J., Magalhães, G.L.G., Soncini, J.G.M. et al. Correction to: Epidemiological and molecular study of Providencia rettgeri outbreak at a university hospital during the COVID‑19 reference center. Int Microbiol (2025). https://doi.org/10.1007/s10123-025-00648-5

Image Credits: AI Generated

DOI:

Keywords: Providencia rettgeri, outbreak, epidemiology, molecular study, COVID-19, healthcare infection control.